Buy & Sell Quest Diagnostics Inc (DGX) – Quest Diagnostics Inc Price Today
Aura AI Summary
Key Stats
- $21.59BMarket Cap
- HealthSector
- -8.99%3M Drawdown
- $27.60BEnterprise Value
- 1.76%Dividend Yield
- 58 daysTypical Hold Time
Quest Diagnostics Inc (DGX) is currently valued at a market capitalization of $21.59B, with an enterprise value of $27.60B. Over the past 52 weeks, Quest Diagnostics Inc has traded between a low of $166.42 and a high of $211.91, highlighting its annual price range. Over the past three months, Quest Diagnostics Inc has recorded a drawdown of -8.99%, reflecting recent price volatility. Quest Diagnostics Inc offers a dividend yield of 1.76%, with the most recent dividend of $0.86 paid on 06 Apr 26. On average, investors hold Quest Diagnostics Inc for approximately 58 days, indicating typical investor behavior on the platform.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Most Recent News
Austria's iShares MSCI ETF offers yield but faces dividend cuts amid slowing bank earnings and ECB easing.
The iShares MSCI Austria ETF (EWO) has gained 55% in a year, driven by price gains and dividend income mainly from Austrian banks like Erste Group. However, its dividend payments have recently declined due to slowing bank earnings amid a slowing euro...

Nobel laureate John Jumper leaves DeepMind to join AI rival Anthropic
John Jumper, a Nobel Prize-winning scientist known for leading DeepMind's AlphaFold team, announced his departure from DeepMind after nearly nine years to join Anthropic, a competing AI company. Jumper's work on AlphaFold, which predicts protein stru...

SpaceX shares cool after IPO surge but index inclusion could boost demand again
SpaceX's stock surged 67% above its IPO price shortly after debut but has since cooled to a 33% gain. The initial excitement is fading, yet the company is expected to be added to stock indexes soon. This inclusion could attract a new wave of investor...
